🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Knoll Capital Management - Q4 2025 13F Filings

KN

Knoll Capital Management, LLC

CIK: 0001325083
Address: Florida Miami 201 S. Biscayne Blvd Suite 800
$218.01 M
Portfolio Value
33
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 11/16/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025

Top Sells

Q4 2025
−$8.76 M
−$1.66 M
−$644,152
5. Hookipa Pharma
−$461,228

Asset Allocation

Stocks/ETFs
+16.83%
$218.01 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Knoll Capital Management Q4 2025 Filing Summary

Knoll Capital Management, LLC filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 218.01 M reflecting a +16.83% change from the prior quarter, spanning 33 assets. The top 10 holdings comprised 67.7% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 6 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Knoll Capital Management’s Q4 2025 Filing

Knoll Capital Management submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Knoll Capital Management reported a managed portfolio value of 218.01 M, consisting of 34 individual positions.

This page displays the raw filing documents. To see which stocks Knoll Capital Management bought or sold during Q4 2025, please visit Knoll Capital Management's Portfolio Analysis page.